 |
|
|
| |
Efficacy and Safety of Switching to DTG/3TC in Virologically Suppressed PLWH by Age, Including Those Aged ≥65 Years: Pooled Results From the TANGO and SALSA Studies
|
| |
| |
IDWeek 2022; October 19-23, 2022; Virtual and Washington, DC
Manyu Prakash,1 Richard Grove,2 Brian Wynne,3 Choy Man,3 Jean van Wyk,1 Bryn Jones,1 Chinyere Okoli,1 Emilio Letang,4 Mounir Ait-Khaled,1 Andrew Clark1
1ViiV Healthcare, Brentford, UK; 2GSK, Brentford, UK; 3ViiV Healthcare, Durham, NC, USA; 4ViiV Healthcare, Madrid, Spain
|
| |
|
|
|
|
|
